Successful Treatment of Sarcoidosis-associated Pulmonary Hypertension with Corticosteroids
Overview
Authors
Affiliations
We report a case of sarcoidosis presenting with cor pulmonale of a greater severity than would be expected from the degree of hypoxia and pulmonary fibrosis. Right heart catheterization revealed that mean pulmonary artery pressure was markedly increased (42 mm Hg), was not reduced by supplemental oxygen, but was reduced significantly (25 mm Hg) after 16 weeks of therapy with corticosteroids. Improvement in symptoms and pulmonary function was maintained for an 18-month period of observation after cessation of corticosteroid therapy.
Sarcoidosis-Associated Pulmonary Hypertension.
Morimatsu Y, Tahara N, Okamoto M, Bekki M, Tahara A, Eto Y Medicina (Kaunas). 2025; 61(2).
PMID: 40005458 PMC: 11857724. DOI: 10.3390/medicina61020342.
The Association between ESR and CRP and Systemic Hypertension in Sarcoidosis.
Mirsaeidi M, Omar H, Ebrahimi G, Campos M Int J Hypertens. 2016; 2016:2402515.
PMID: 27433355 PMC: 4940541. DOI: 10.1155/2016/2402515.
Sarcoidosis-associated pulmonary hypertension: Clinical features and outcomes in Arab patients.
Alhamad E, Idrees M, Alanezi M, AlBoukai A, Shaik S Ann Thorac Med. 2010; 5(2):86-91.
PMID: 20582173 PMC: 2883203. DOI: 10.4103/1817-1737.62471.
[Interstitial lung diseases and pulmonary hypertension].
Hauber H Internist (Berl). 2009; 50(9):1072, 1074-6, 1078-9.
PMID: 19575171 DOI: 10.1007/s00108-009-2339-5.
Treatment of sarcoidosis-associated pulmonary hypertension. A two-center experience.
Barnett C, Bonura E, Nathan S, Ahmad S, Shlobin O, Osei K Chest. 2009; 135(6):1455-1461.
PMID: 19118270 PMC: 2821289. DOI: 10.1378/chest.08-1881.